Global Blood Therapeutics, Inc. Human Resources Contracts & Agreements
25 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Change of Control Agreements (7)
- Compensation Agreements (4)
- Employment Agreements (8)
- Non-Employee Director Compensation Policy (Filed With SEC on February 23, 2022)
- Amended and Restated Severance and Change in Control Policy (Filed With SEC on February 23, 2022)
- Amended and Restated U.S. Cash Incentive Bonus Plan (Filed With SEC on February 23, 2022)
- Employment Offer Letter Agreement by and between the Registrant and Carrie Krehlik, dated June 15, 2021 (Filed With SEC on November 4, 2021)
- Employment Offer Letter Agreement by and between the Registrant and Kim Smith-Whitley, M.D., dated November 24, 2020 (Filed With SEC on August 3, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2021)
- Amended and Restated Severance and Change in Control Policy (Filed With SEC on February 24, 2021)
- Amended and Restated Cash Incentive Bonus Plan (Filed With SEC on February 24, 2021)
- Amended and Restated 2015 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on February 24, 2021)
- Amended and Restated Severance and Change in Control Policy (amended and restated through May 26, 2020) (Filed With SEC on August 5, 2020)
- Non-Employee Director Compensation Policy, as amended and restated on March 24, 2020 (Filed With SEC on May 6, 2020)
- Cash Incentive Bonus Plan (Filed With SEC on January 9, 2020)
- Amended and Restated Severance and Change in Control Policy (Filed With SEC on January 9, 2020)
- Change in Control Policy (Filed With SEC on November 7, 2019)
- Employment Offer Letter by and between the Registrant and Eric Fink, dated June 17, 2019 (Filed With SEC on August 7, 2019)
- Employment Offer Letter by and between the Registrant and Jung Choi, dated March 16, 2015 (Filed With SEC on May 10, 2019)
- Employment Offer Letter by and between the Registrant and Brian Cathers, Ph.D., dated January 21, 2019 (Filed With SEC on February 27, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on February 27, 2019)
- Employment Offer Letter Agreement by and between Registrant and David Johnson, dated February 21, 2018 (Filed With SEC on May 7, 2018)
- Employment Offer Letter Agreement by and between Registrant and Jung Choi, dated March 16, 2015 (Filed With SEC on May 7, 2018)
- Employment Offer Letter Agreement by and between Registrant and Peter Radovich, dated October 15, 2014 (Filed With SEC on May 7, 2018)
- Change in Control Policy (Filed With SEC on May 7, 2018)
- Global Blood Therapeutics, Inc. (the Company) Change in Control Policy Adopted on July 23, 2015 (amended on January 6, 2016, July 5, 2017 and July 26, 2017) (Filed With SEC on August 1, 2017)
- GLOBAL BLOOD THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on January 12, 2016)
- GLOBAL BLOOD THERAPEUTICS, INC. 2015 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on July 31, 2015)
